279 related articles for article (PubMed ID: 29660787)
1. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J
Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787
[TBL] [Abstract][Full Text] [Related]
2. GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.
Wu X; Wang H; Lian Y; Chen L; Gu L; Wang J; Huang Y; Deng M; Gao Z; Huang Y
Sci Rep; 2017 Jul; 7(1):5129. PubMed ID: 28698581
[TBL] [Abstract][Full Text] [Related]
3. GTSE1 promotes tumor growth and metastasis by attenuating of KLF4 expression in clear cell renal cell carcinoma.
Chen W; Wang H; Lu Y; Huang Y; Xuan Y; Li X; Guo T; Wang C; Lai D; Wu S; Zhao W; Mai H; Li H; Wang B; Ma X; Zhang X
Lab Invest; 2022 Sep; 102(9):1011-1022. PubMed ID: 35585131
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer.
Liu A; Zeng S; Lu X; Xiong Q; Xue Y; Tong L; Xu W; Sun Y; Zhang Z; Xu C
Int J Biol Macromol; 2019 Feb; 123():322-334. PubMed ID: 30414902
[TBL] [Abstract][Full Text] [Related]
5. GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
Lin F; Xie YJ; Zhang XK; Huang TJ; Xu HF; Mei Y; Liang H; Hu H; Lin ST; Luo FF; Lang YH; Peng LX; Qian CN; Huang BJ
J Exp Clin Cancer Res; 2019 Apr; 38(1):152. PubMed ID: 30961661
[TBL] [Abstract][Full Text] [Related]
6. Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.
Guo L; Zhang S; Zhang B; Chen W; Li X; Zhang W; Zhou C; Zhang J; Ren N; Ye Q
Cell Biol Toxicol; 2016 Aug; 32(4):263-74. PubMed ID: 27240802
[TBL] [Abstract][Full Text] [Related]
7. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
[TBL] [Abstract][Full Text] [Related]
8. GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling.
Zhang F; Meng J; Jiang H; Feng X; Wei D; Meng W
Anal Cell Pathol (Amst); 2021; 2021():5589532. PubMed ID: 34007784
[TBL] [Abstract][Full Text] [Related]
9. GTSE1 promotes the growth of NSCLC by regulating microtubule-associated proteins through the ERK/MAPK pathway.
Wang C; Wen M; Xu J; Gao P; Liu S; Liu J; Chen Y; Zhou L
Thorac Cancer; 2023 Jun; 14(17):1624-1634. PubMed ID: 37079439
[TBL] [Abstract][Full Text] [Related]
10. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
11. Gene expression screening identifies CDCA5 as a potential therapeutic target in acral melanoma.
Xu T; Ma M; Dai J; Yu S; Wu X; Tang H; Yu J; Yan J; Yu H; Chi Z; Si L; Sheng X; Cui C; Kong Y; Guo J
Hum Pathol; 2018 May; 75():137-145. PubMed ID: 29452217
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of downregulated NISCH expression in skin cutaneous melanoma: Modulation of tumor cell invasion, migration, and EMT via PAK1 inhibition.
Hua HK; Zhu HM; Zhang ZG
Tissue Cell; 2024 Jun; 88():102399. PubMed ID: 38723330
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
14. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
19. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of GTSE1 leads to the inhibition of proliferation, migration, and Warburg effect in cervical cancer by blocking LHDA expression.
Chen L; Zhong Y; Yang X; Zhang Q; Wu X
J Obstet Gynaecol Res; 2021 Nov; 47(11):3913-3922. PubMed ID: 34482592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
